Andere Kunden interessierten sich auch für
![Uterine Cancer]( "Uterine Cancer")
Uterine Cancer186,99 €![Uterine Fibroids and Adenomyosis]( "Uterine Fibroids and Adenomyosis")
Uterine Fibroids and Adenomyosis74,99 €![Pathology of Female Cancers]( "Pathology of Female Cancers")
Pathology of Female Cancers110,99 €![Rectal Cancer]( "Rectal Cancer")
Rectal Cancer110,99 €![Rectal Cancer]( "Rectal Cancer")
Rectal Cancer81,99 €![Uterine Cervical Cancer]( "Uterine Cervical Cancer")
Uterine Cervical Cancer106,99 €![Lung Cancer:]( "Lung Cancer:")
Lung Cancer:148,99 €
There are an estimated 41,000 new cases of Uterine and Endometrial Cancer each year in the United States alone, resulting in roughly 7300 deaths. In Uterine Cancer: Screening, Diagnosis and Treatment, Franco Muggia, Esther Oliva and a panel of prominent medical and gynecologic oncologists survey all aspects of Uterine and Endometrial Cancer, including current screening methods, staging and prognostic factors, and available treatment options. The discussion includes the role of imaging in the diagnosis and treatment of endometrial cancer, the molecular pathology and genetics of uterine cancer and the essential epidemiology of cancer of the endometrium. Authoritative and highly practical, Uterine Cancer: Screening, Diagnosis and Treatment is the definitive text on the most common cancer of the female genital tract, and a must-have for all gynecological residents and fellows, as well as gynecological oncologists and family practice doctors who wish to provide their patients with the best possible care.
For the Editors, the task of writing a Preface is most satisfying. It represents the completion of the book and a moment of reflection on whether the whole is more than the sum of all the parts. And also, one must reflect on how this book is likely to be utilized in this era of rapid communications. The Editors first met in May 2003 at a stimulating Italian symposium on endometrial cancer (organizers Drs. Luigi Frigerio, Roberto Grassi and Andrea Lissoni, with participation of the deans of Italian Gynecologic Oncology, Ugo Bianchi and Constantino Mangioni) that took place at Bergamo and Caravaggio. The impressive gains in biology and clinical trials were further discussed by the two editors and others that are co-authors in this venture on this side of the Atlantic at a 2004 Educational Session at the American Society of Clinical Oncology (ASCO). The pace of progress in various aspects of management of uterine cancer was no- worthy, not only was tumor biology fueling novel hypotheses such as questioning the mesenchymal origin of carcinosarcomas, but knowledge of molecular pathways was beginning to be applied as prognostic and as predictive factors portending benefit from systemic therapies. Surgical staging and sensitive imaging provided the underpinning for refining our treatment algorithms. Finally, a role for che- therapy had finally become established, principally through phase III studies c- paring chemotherapy to radiation in mostly locally advanced stages III and IV that had undergone resection.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
For the Editors, the task of writing a Preface is most satisfying. It represents the completion of the book and a moment of reflection on whether the whole is more than the sum of all the parts. And also, one must reflect on how this book is likely to be utilized in this era of rapid communications. The Editors first met in May 2003 at a stimulating Italian symposium on endometrial cancer (organizers Drs. Luigi Frigerio, Roberto Grassi and Andrea Lissoni, with participation of the deans of Italian Gynecologic Oncology, Ugo Bianchi and Constantino Mangioni) that took place at Bergamo and Caravaggio. The impressive gains in biology and clinical trials were further discussed by the two editors and others that are co-authors in this venture on this side of the Atlantic at a 2004 Educational Session at the American Society of Clinical Oncology (ASCO). The pace of progress in various aspects of management of uterine cancer was no- worthy, not only was tumor biology fueling novel hypotheses such as questioning the mesenchymal origin of carcinosarcomas, but knowledge of molecular pathways was beginning to be applied as prognostic and as predictive factors portending benefit from systemic therapies. Surgical staging and sensitive imaging provided the underpinning for refining our treatment algorithms. Finally, a role for che- therapy had finally become established, principally through phase III studies c- paring chemotherapy to radiation in mostly locally advanced stages III and IV that had undergone resection.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
From the reviews: "This short monograph comprises 15 chapters written by 31 contributors and covers the epidemiology, pathology, staging, and management of uterine cancers. ... This book provides some useful background on endometrial cancer and ... helpful for a radiation oncologist with a special interest in gynecologic cancers. ... directed primarily at an audience of gynecologic oncologists ... ." (David S. Shimm, International Journal of Radiation - Oncology - Biology - Physics, Vol. 77 (2), 2010)